Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MLANA antibody

This Mouse Monoclonal antibody specifically detects MLANA in IHC (p). It exhibits reactivity toward Human, Mouse and Rat.
Catalog No. ABIN3026558

Quick Overview for MLANA antibody (ABIN3026558)

Target

See all MLANA Antibodies
MLANA (Melan A (MLANA))

Reactivity

  • 211
  • 119
  • 94
  • 37
  • 16
  • 1
Human, Mouse, Rat

Host

  • 107
  • 104
  • 1
Mouse

Clonality

  • 136
  • 76
Monoclonal

Conjugate

  • 78
  • 16
  • 11
  • 9
  • 9
  • 9
  • 9
  • 9
  • 9
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
This MLANA antibody is un-conjugated

Application

  • 142
  • 102
  • 101
  • 81
  • 78
  • 53
  • 26
  • 26
  • 24
  • 24
  • 20
  • 13
  • 9
  • 9
  • 2
  • 1
  • 1
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone

M2-9E3
  • Characteristics

    This antibody recognizes a protein doublet of 20-22 kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. There are seven other melanoma associated antigens recognized by autologous cytotoxic T cells: MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MART-1 antibody labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. The antibody does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.

    Purification

    Protein G affinity chromatography

    Immunogen

    Recombinant human Melan-A protein was used as the immunogen for this antibody.

    Isotype

    IgG2b kappa
  • Application Notes

    The concentration stated for each application is a general starting point. Variations in protocols, secondaries and substrates may require the Melan-A antibody to be titered up or down for optimal performance.

    1. Staining of formalin-fixed tissues is enhanced by boiling tissue sections in 10  mM Citrate Buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes.
    2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Prediluted IHC only format : incubate for 30 min at RT (2)

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Prediluted in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide, *For IHC use only*

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store the Melan-A antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
  • Target

    MLANA (Melan A (MLANA))

    Alternative Name

    Melan-A

    Background

    This antibody recognizes a protein doublet of 20-22  kDa, identified as MART-1 (Melanoma Antigen Recognized by T cells 1) or Melan-A. MART-1 is a melanocyte differentiation antigen recognized by autologous cytotoxic T lymphocytes. There are seven other melanoma associated antigens recognized by autologous cytotoxic T cells: MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1. Subcellular fractionation shows that MART-1 is present in melanosomes and endoplasmic reticulum. This MART-1 antibody labels melanomas and other tumors showing melanocytic differentiation. It is also a useful positive-marker for angiomyolipomas. The antibody does not stain tumor cells of epithelial, lymphoid, glial, or mesenchymal origin.

    Gene ID

    2315
You are here:
Chat with us!